Roche Launches Accu-Chek Guide Blood Glucose Monitoring System

Roche announced the launch of the Accu-Chek Guide, the next-generation blood glucose monitoring system. This new system is designed to make everyday blood glucose (BG) monitoring easier with features such as the spill-resistant SmartPack test strip vial, which helps users to remove one strip at a time and avoid spillage or contamination. The Accu-Chek Guide system also provides for advanced accuracy, which enables reliable diabetes management. “As the global leader in diabetes management we are dedicated to supporting people with diabetes, in thinking less about their daily therapy routines. We are very excited to introduce this innovative system, that simplifies blood glucose monitoring and improves the testing experience,” said Roland Diggelmann, CEO Roche Diagnostics. First markets to launch the new system are Denmark, Switzerland and Australia. More countries will follow subsequently starting in early 2017.
 
The Accu-Chek Guide system enables on-board pattern detection that helps to increase awareness of too high or too low glucose readings as well as Bluetooth Low Energy connectivity to the Accu-Chek Connect diabetes management solution via a mobile app. This cloud-based solution guarantees a secure online data exchange and automatic data logging. People with diabetes, caregivers, and healthcare providers can share diabetes information virtually anywhere for timely advice and remote monitoring. Such telemedicine solutions can help people with diabetes and their caregivers manage diabetes more efficiently and give them peace of mind and a feeling of relief. Hence, 97% of 197 participants in a recently published study from France and the US agreed that the system was very easy to use and offers a better testing experience¹.
 
The Accu-Chek Guide system not only fulfills current accuracy standards² but delivers tighter 10/10 accuracy for more reliable results³. Consistently accurate measurements are essential for reliable BG monitoring and deriving the correct therapy decisions^4,5. Large deviations of the measured BG values from the true glucose levels can result in higher HbA1c levels, glycemic excursions and markedly increased rates of hypoglycemic events, as a recently published retrospective study revealed⁶. In addition, studies have demonstrated that only about half of the BG meters evaluated meet the minimum accuracy requirements as defined by the ISO 15197:2013/EN ISO 15197:2015 standard^7,8.
 
References
¹Harvey C., et al., J Diabetes Sci Technol July 2016; Published online before print July 6, 2016, DOI: 10.1177/1932296816658058
²International Organization for Standardization (ISO). ISO 15197:2013.http://www.iso.org/iso/catalogue_detail?csnumber=54976
³Brazg R., et al. J Diabetes Sci Technol June 2016; Published online before print June 5, DOI: 10.1177/1932296816652902
⁴Brazg R., et al. J Diabetes Sci Technol 2013;7:144-152
⁵Ginsberg B., J Diabetes Sci Technol. Jul 2009;3(4):903-913
⁶Boettcher, C. et al., Diabetes Technol Ther. Apr 2015;17(4):275-282
⁷Freckmann G,et al., J Diabetes Sci Technol. Sep 2012;6(5):1060-1075
⁸Baumstark A, et al., J Diabetes Sci Technol. Sep 2012;6(5):1076-1086